a16z Capital Management, L.L.C. Diversified Active

Location: Menlo Park, CA

CIK: 0001540358 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 14, 2026

Total Value: $14.21B (100.0% shares, 0.0% debt)

Holdings (19)

Exited Positions (1)

Decreased Positions (3)

Unchanged Positions (12)

NAVN NAVAN INC 4.5%
Value $645M Shares 28,218,676 Share Price $22.87 Est. Cost/Share — Unrealized @ Report Date —
RVMD REVOLUTION MEDICINES INC 1.2%
Value $173M Shares 921,099 Share Price $187.28 Est. Cost/Share — Unrealized @ Report Date —
BIOA BIOAGE LABS INC 0.6%
Value $79.24M Shares 3,233,170 Share Price $24.51 Est. Cost/Share — Unrealized @ Report Date —
XYZ BLOCK INC 0.5%
Value $77.27M Shares 1,016,697 Share Price $76.00 Est. Cost/Share — Unrealized @ Report Date —
ERAS ERASCA INC 0.4%
Value $52.44M Shares 2,862,500 Share Price $18.32 Est. Cost/Share — Unrealized @ Report Date —
AKTS AKTIS ONCOLOGY INC 0.1%
Value $13.38M Shares 415,000 Share Price $32.23 Est. Cost/Share — Unrealized @ Report Date —
BTGO BITGO HOLDINGS INC 0.0%
Value $3.452M Shares 666,356 Share Price $5.18 Est. Cost/Share — Unrealized @ Report Date —
META META PLATFORMS INC 0.8%
Value $120M Shares 212,531 Share Price $563.29 Est. Cost/Share — Unrealized @ Report Date —
DNA GINKGO BIOWORKS HOLDINGS INC 0.0%
Value $1.076M Shares 108,568 Share Price $9.91 Est. Cost/Share — Unrealized @ Report Date —
GLTO DAMORA THERAPEUTICS INC 0.2%
Value $32.15M Shares 1,236,157 Share Price $26.01 Est. Cost/Share — Unrealized @ Report Date —
CAMP CAMP4 THERAPEUTICS CORP 0.1%
Value $9.288M Shares 2,125,339 Share Price $4.37 Est. Cost/Share — Unrealized @ Report Date —
MAZE MAZE THERAPEUTICS INC 0.4%
Value $50.79M Shares 1,702,225 Share Price $29.84 Est. Cost/Share — Unrealized @ Report Date —